Tripod Preclinical Research Laboratories Stock

Tripod provides preclinical research services for global pharma companies, R&D enterprises and institutes and medical device developers.

Sign up today and learn more about Tripod Preclinical Research Laboratories Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Tripod Preclinical Research Laboratories Stock

Tripod is a Contract Research Organization in the biopharmaceutical space that provides preclinical research services for global pharma companies, R&D enterprises and institutes, and medical device developers. Tripod (TPR) is dedicated to nonclinical research (drug safety evaluation) for the candidates of new chemical entity (NCE), food additives, biologics,pesticides,veterinary drugs, and new cosmetics.

Funding History

November 2021$1.0B
April 2023$37.8M

Management

Chief Executive Officer

Xuefeng Zhang

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo